Relay Therapeutics, Inc. (RLAY)
19.76
+0.32
(+1.65%)
USD |
NASDAQ |
Aug 24, 16:00
19.76
0.00 (0.00%)
After-Hours: 20:00
Relay Therapeutics Gross Profit Margin (Quarterly) : -2.86% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.86% |
| March 31, 2026 | 83.20% |
| December 31, 2025 | 91.44% |
| September 30, 2025 | |
| June 30, 2025 | -48.01% |
| March 31, 2025 | 84.27% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | 86.06% |
| December 31, 2023 | |
| September 30, 2023 | 94.59% |
| Date | Value |
|---|---|
| June 30, 2023 | -1.02K% |
| March 31, 2023 | -429.6% |
| December 31, 2022 | -360.9% |
| September 30, 2022 | -200.3% |
| June 30, 2022 | -161.9% |
| March 31, 2022 | -132.7% |
| December 31, 2021 | -82.36% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 98.90% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | 83.71% |
| United Therapeutics Corp. | 87.30% |
| AbbVie, Inc. | 74.71% |
| TG Therapeutics, Inc. | 82.86% |
| Travere Therapeutics, Inc. | 96.22% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.41% |
| Return on Assets | -38.79% |
| Return on Invested Capital | -40.46% |
| Profit Margin (Quarterly) | -23.92K% |
| Operating Margin (Quarterly) | -25.95K% |
| Return on Net Operating Assets | -497.1% |